PubMed · 14362993
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
1955. TUBERCULOSIS control.. https://pubmed.ncbi.nlm.nih.gov/14362993/
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
Yet another guideline on the prevention of infective endocarditis has been published, this time limiting prophylaxis to high-risk patients.
There is currently no consensus regarding the use of antibiotic prophylaxis in breast surgery. This postal survey aimed to establish the current practice in perioperative antibiotic use for breast surgery in the United Kingdom. Questionnaires were sent to 406 breast surgeons, enquiring about antibiotic use for common breast procedures. A total of 266 completed questionnaires were returned (65.5%). Over 80% of surgeons who performed breast augmentations, myocutaneous flap reconstructions and implant reconstructions used antibiotic prophylaxis. Up to 33% used antibiotic prophylaxis for wide local excisions (WLEs), mastectomies and axillary surgery for breast cancer, while 62% and 45% used antibiotics for breast reductions and duct excisions, respectively. The most common antibiotic used was co-amoxiclav. The variation in practice regarding antibiotic prophylaxis in breast surgery reflects the lack of reliable evidence for its efficacy. Further randomised controlled trials are required, taking into consideration specific risk factors affecting postoperative infection rate for breast surgery.
Explore the source record for details and available documents.